| Drug Name: | Oxybutynin Chloride |
| Manufacturer: | Pharmaceutical Associates, Inc. |
| Other Info: | |
| Clinical Trials: | |
Oxybutynin chloride is contraindicated in patients with untreated angle closure glaucoma and in patients with untreated narrow anterior chamber angles since anticholinergic drugs may aggravate these conditions.
It is also contraindicated in partial or complete obstruction of the gastrointestinal tract, paralytic ileus, intestinal atony of the elderly or debilitated patient, megacolon, toxic megacolon complicating ulcerative colitis, severe colitis, and myasthenia gravis.
It is contraindicated in patients with obstructive uropathy and in patients with unstable cardiovascular status in acute hemorrhage.Oxybutynin chloride is contraindicated in patients who have demonstrated hypersensitivity to the product.Oxybutynin chloride, when administered in the presence of high environmental temperature, can cause heat prostration (fever and heat stroke due to decreased sweating).Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy.
In this instance, treatment with oxybutynin chloride would be inappropriate and possibly harmful.Oxybutynin chloride may produce drowsiness or blurred vision.
The patient should be cautioned regarding activities requiring mental alertness such as operating a motor vehicle or other machinery or performing hazardous work while taking this drug.Alcohol or other sedative drugs may enhance the drowsiness caused by oxybutynin chloride.